Carbon 44 (2006) 11061111

www.elsevier.com/locate/carbon

In vitro studies of carbon nanotubes biocompatibility

a,*
J. Chopek , B. Czajkowska b, B. Szaraniec a, E. Frackowiak c,
K. Szostak c,d, F. Beguin d
a
AGH University of Science and Technology, Faculty of Materials Science and Ceramics, Department of Biomaterials,
al. Mickiewicza 30, 30-059 Krakow, Poland
b
Collegium Medicum of the Jagiellonian University, Department of Immunology, ul. Czysta 18, 31-121 Krakow, Poland
c
Poznan University of Technology, ul. Piotrowo 3, 60-965 Poznan, Poland
d
CRMD, CNRS-University, 1B rue de la Ferollerie, 45071 Orleans Cedex 02, France

Received 17 November 2005; accepted 22 November 2005

Available online 6 January 2006

Abstract

Cellular tests have been applied to study the biocompatibility of high purity multiwalled carbon nanotubes (MWNTs). The viability
of broblasts, osteoblasts and osteocalcin concentrations in osteoblasts cultures in the presence of nanotubes has been examined, as well
as the degree of cells stimulation, based on the amount of released collagen type I, IL-6 and oxygen free radicals. The high level of via-
bility of the examined cells in contact with the nanotubes, the slight increase of collagen formation, the lack of pro-inammatory IL-6
cytokine as well as the induction of free radicals, conrm a good biocompatibility of nanotubes, which is similar to that of polysulfone
currently used in medicine. The collagen synthesis induced on nanotubes by both broblasts and osteoblasts may be signicant for future
medical applications of nanotubes, in particular as substrates for the regeneration of tissues.

2005 Elsevier Ltd. All rights reserved.

Keywords: Carbon nanotubes; Biocompatibility

1. Introduction The electronic structure and the surface morphology of

Carbon nanotubes, due to their specic structure/tex-
ture and properties, may play a signicant role in the devel-
opment of carbon materials for medicine, the main body of
which includes pyrocarbons, glassy carbon, carbon bers,
carboncarbon composites, and diamond-like layers [1
4]. The medical applications of these materials are deter-
mined by the following properties: biocompatibility in
contact with blood, bone, cartilage and soft tissues;
biofunctionality understood as the ability of taking over
certain functions of tissues by a mutual adjustment of
implants and tissues properties [57]. Fields of current
applications of carbon biomaterials are given in Table 1.
*
Corresponding author. Fax: +48 12 633 15 93.
E-mail address: chlopek@uci.agh.edu.pl (J. Chopek).
carbon nanotubes, which probably determine their bio-
compatibility, are typical of graphite-like structures [11].
They can be distinguished by a tubular construction in
the nanometer range and by high strength and Young
modulus [12]. The combination of these properties may
open new elds of application, including those in medicine.
Like other brous materials, nanotubes can be used as sub-
strates for the regeneration of tissue. Due to their high elec-
trical conductivity, the latter process can be additionally
assisted by electrostimulation during the cell cultures and
the tissue formation [13].
Two forms of carbon nanotubes can exist: single-wall
(SWNTs) and multiwalled (MWNTs) [14,15]. They can
be open-ended after specic chemical treatments [16], or
may have closed tips. In the latter case they may be used
as biosensors [17]. The accessible canals of open-ended
nanotubes may facilitate the migration of metabolites or

0008-6223/$ - see front matter
2005 Elsevier Ltd. All rights reserved.
doi:10.1016/j.carbon.2005.11.022
 J. Chopek et al. / Carbon 44 (2006) 11061111
Table 1
Examples of applications of carbon biomaterials [810]
Type of material Function
Carboncarbon composites Bone xation
Braided carbon bers Tissue knitting, reconstruction of joint
ligaments and tendons
Unwoven carbon fabric Filling bone and cartilage losses
Coatings of diamond-like Coating of metal implantscorrosion
carbon (DLC) protection
Glassy carbon Blood ow regulation
growth agents, and may also be used as a drug carrier [18].
Very good mechanical properties, the possibility of surface
machining as well as the ability to form functional groups
constitute good fundaments for the use of nanotubes in the
fabrication of composite materials.
The possibility of forming composites with polymer
matrices, both biostable (polysulfone, PEEK), and biore-
sorbable (PLA, PGLA, co-polymers) is of particular
importance in the case of medical applications [1921].
This opens opportunities for the manufacture of multifunc-
tional implants useful in many areas of medicine. However,
with resorbable polymers, the relation between the resorp-
tion time and the time of tissue healing is of signicant
importance. A too high resorption rate may lead to a
release of nanotubes from the composite materials into
the living body.
In the case of the ceramic matrix composites, an
improvement of the fracture toughness can be expected,
which may be particularly important in the case of manu-
facturing reinforced nanostructure ceramics. The nano-
composite system of nanotubes reinforced hydroxyapatite
[22] may be included in this category.
The use of the advantages of nanotubes in medical
applications, particularly their tubular morphology and
their excellent electrical and mechanical properties relies
heavily on their biocompatibility. Although both the nat-
ure of carbon and positive experiences to date with various
forms of carbon would suggest also a good biocompatibil-
ity of nanotubes, basic cellular tests must be performed in
order to allow projects and application works to be opened
in medicine. In the present work, the viability of bro-
blasts, osteoblasts and osteocalcin concentrations in osteo-
blasts cultures in the presence of high purity multiwalled
carbon nanotubes (MWNTs) has been examined, as well
as the degree of cells stimulation, based on the amount of
released collagen type I, IL-6 and oxygen free radicals.
2. Experimental
2.1. Preparation and characterization of the nanotubes
In our experiments, we used high purity multiwalled car-
bon nanotubes (MWNTs) prepared by catalytic decompo-
sition of acetylene on a CoO/MgO solid solution catalyst,
according to the process described in Refs. [23,24]. This
process allows a large scale and selective production of
1107
Type of implant Area of medicine
Screws, plates, nails, stems of endoprosthesis Bone surgery
Surgical sutures, ligament and tendons prosthesis Orthopedics
Disks and rings Bone surgery
Joint endoprosthesis, screws Bone surgery
Heart valves Cardiology
MWNTs, free of any disordered carbon, that makes the
purication very easy by simple dissolution of the catalyst
precursor in HCl. The elemental analysis on the puried
material gives: C = 96 wt%, H = 0.85 wt%, Mg = 200 ppm
and Co = 2 wt%. The low magnesium and cobalt content
shows that the treatment in hydrochloric acid is very
ecient.
The structure and texture of the puried carbon nano-
tubes was controlled by scanning electron microscopy
(SEM, Hitachi S 4200) and transmission electron micros-
copy (TEM, Philips CM 20). For the TEM observations,
the samples were ground in ethanol and dropped over a
copper holey grid covered by amorphous carbon. The
SEM picture presented in Fig. 1 shows a very dense and
entangled network of nanotubes, where graphitic particles,
disordered carbon and nanocapsules are completely absent.
The TEM observation (Fig. 2) demonstrates that this
material consists exclusively of multiwalled nanotubes.
The high-resolution images show that the central canal is
quite well dened (from 2 to 5 nm in diameter) and the
walls consist of an average number of 1015 continuous
layers oriented in parallel to the tube axis. Most of the car-
bon nanotubes have closed tips and for only few of them
cobalt particles are encapsulated near the tip or inside the
canal. The histogram of the outer diameters (Fig. 3) shows
a good calibration of the carbon nanotubes, with outer
diameters mostly in the range from 10 to 15 nm. The histo-
gram of the inner diameters (diameters of the central
canal), ranges mainly in a narrow range from 2 to 5 nm.
Fig. 1. SEM micrograph of the puried nanotubes produced by the
catalytic decomposition of acetylene at 600 C over the CoO/MgO solid
solution.
1108 J. Chopek et al. / Carbon 44 (2006) 11061111
Fig. 2. TEM image of the puried nanotubes produced by the catalytic
decomposition of acetylene at 600 C over the CoO/MgO solid solution.
Fig. 3. Histogram of the outer diameters of the puried carbon nanotubes
produced by the decomposition of acetylene at 600 C over the CoO/MgO
solid solution.
Even if MWNTs with outer diameters up to 30 nm were
observed during the TEM observations, it can be con-
cluded that the inner diameter always remains in the same
range, being probably more strictly controlled by the cata-
lyst particle size.
The above described nanotubes together with polysulf-
one PSU (C27H26O6S)n from Aldrich (molecular mass
M = 26,000, glassy transition Tg = 190 C, density
d = 1.24 g/cm3) have been used for the samples prepara-
tion. The choice of PSU resulted from its good biocompat-
ibility (this polymer is currently used in medicine) and the
necessity to manufacture a composite material, in which
the nanotubes can modify the mechanical and biological
properties. Polysulfone was dispersed in methylene chlo-
ride (CH2Cl2), poured onto a Petri platter and then covered
with nanotubes. After solvent evaporation, a thin polymer
lm containing the nanotubes with a thickness of about
1.8 lm was obtained. A pure polysulfone lm was used
as a reference sample.
2.2. Cellular tests
The cellular viability was determined after 24 h, 48 h
and 7 day cultures in order to get an initial evaluation of
the biocompatibility of pure polysulfone and polysulfone
with nanotubes. The level of secreted collagen type I,
IL-6 and osteocalcine was also dened. The degree of
macrophages activation to secrete free radicals under the
inuence of nanotubes was determined indirectly. The
following cellular lines, from American Type Culture
Collection (ATCC), and the media recommended by
ATCC were used:
Human osteoblastic line hFOB 1.19 ATCC CRL-11372
in 1:1 mixture of Hams F12 medium and Dulbeccos
modied Eagles medium with 2.5 10 3 mol l 1 L-glu-
tamine and 0.3 mg/ml G418 with 10% of foetal bovine
serum.
Human broblastic line HS-5 ATCC CRL-11882 in
RPMI with 15% bovine serum.
The cell cultures were run in 12-well plates at the bottom
of which the samples of polysulfone and polysulfone with
nanotubes were placed, and 2 cm3 of the cells suspension
in the culture medium were added. The cultures were run
in an incubator under 5% CO2/95% air atmosphere at
37 C (broblasts) or 34 C (osteoblasts) over 7 days. After
24 h, 48 h and 7 days, the viability of the cells was
examined by Cell Titer 96 Aqueous One Solution Cell
Proliferation Assay (Promega) [25]. The main reagent in
this method contains a tetrazolium compound (MTS,
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolim, inert salt) and an electron
coupling reagent (phenazin ethosulfate; PES). The MTS
tetrazolium compound is bioreduced by the cells into a col-
oured formazan product which is soluble in the tissue cul-
ture medium. The quantity of formazan formed, measured
by the absorbance at 490 nm, is directly proportional to the
number of living cells in the culture. The results have been
presented in percentage, adopting 100% of transmittance
for reference cells, i.e. cultures without materials.
The level of secreted collagen I (the protein constituting
the building material of connective tissue as well as bones,
skin and vessel walls) was determined together with the
level of IL-6 cytokine (contributing in inammation reac-
tions) in the supernatant liquids over 7 day cultures of oste-
oblasts and broblasts. The ELISA (Enzyme-Linked
Immunoabsorbent Assay) test was used with bioproducts
and endogen reagents. In the case of 7-day cultures of oste-
oblasts, the level of osteocalcin, a protein specic of these
cells contributing mainly in bone rearrangement, was deter-
mined in the supernatant liquids. The ELISA test was used,
with the DSL10-7600 Active Human Osteocalcin Enzyme
Linked Immunosorbant Assay Kit, produced by Diagnos-
tic System Laboratories.
The chemiluminescence of mouse peritoneum macro-
phages in RPMI with 15% foetal bovine serum was
examined using a luminometer Lucy 1 (Anthos, Salzburg,
Austria), in order to check if the tested nanotubes acti-
vate the macrophages to produce free radicals, which could
prove their pathogenic character. 50 lg of nanotubes, 50 lg
of carbon particles (carbonized phenolformaldehyde
 J. Chopek et al. / Carbon 44 (2006) 11061111
resin) and opsonized with the mouse serumzymosan
were added to the cells (at a concentration of 5 105),
and photon emission was measured over a period of
60 min.
3. Results and discussion
The examination of broblasts and osteoblasts viability
on polysulfone lms covered with nanotubes indicates a
small decrease of the viability of all the examined cells, as
compared to the viability obtained on pure polysulfone
lms (Fig. 4). This decrease may be related to the nature
of the substance itself, as well as to its surface state. In
the case of other carbon materials, the eect of their surface
roughness on the cells viability was found to be of impor-
tance [26]. The same eect can be expected for the case of
Fig. 4. Viability of broblasts and osteoblasts in contact with PSU and
PSU + nanotubes: ((a) broblasts and (b) osteoblasts). The results
represent the average SD of duplicates from 8 dierent experiments.
Fig. 5. Prolograms of PSU (a) and PSU + nanotubes (b). (RaArith-
metic mean roughness value.)
1109
Fig. 6. Production of collagen on PSU and PSU + nanotubes. The results
represent the average SD of duplicates from 8 dierent experiments.
polysulfone containing nanotubes. The prolographic tests
presented in Fig. 5 conrm a higher degree of roughness for
the samples covered with nanotubes. A similar good cellu-
lar behaviour of carbon nanobers has already been
observed [27,28].
The amount of collagen type I formed is slightly higher
on PSU surfaces covered with nanotubes than on pure
PSU, as particularly shown in Fig. 6 for broblasts and
osteoblasts. These results are very encouraging for the
application of nanotubes in tissue engineering. A more
intensive collagen synthesis may lead to the regeneration
of soft and bone tissues, where nanotubes may constitute
an excellent substrate for their growth.
The level of pro-inammatory cytokine IL-6 has been
also determined in the supernatants over the broblast cul-
tures of the examined materials. The IL-6 can be character-
ized by multidirectional inuences and is considered as one
of the major factors regulating the defensive mechanisms.
Its main role is to participate in the immune response,
the blood formation and the inammatory reactions, since
it is the main stimulator for the generation of the acute
phase proteins by liver. The IL-6 is generated mainly by
macrophages, monocytes, and also by broblasts, endothe-
lium cells and lymphocytes. An increased concentration of
IL-6 in macrophages and broblasts cultures would point
out a same level of stimulation of these cells as in the
50
40
30
pg/ml
20
10
0
Fb PSU PSU+nanotubes
Fig. 7. IL-6 release from broblasts cultured on PSU and PSU + nano-
tubes. The results represent the average SD of duplicates from 4
dierent experiments.
1110 J. Chopek et al. / Carbon 44 (2006) 11061111
Fig. 8. Osteocalcin concentrations in osteoblasts culture. The results
represent the average SD of duplicates from 4 dierent experiments.
Fig. 9. Chemiluminescence of macrophages (Mf) stimulated with zymo-
san, carbon particles and nanotubes.
inammatory reaction [29]. In fact, Fig. 7 shows that there
is not any induction of pro-inammatory IL-6 by PSU and
PSU with nanotubes.
The same eect was observed for osteocalcin released
from osteoblasts (Fig. 8). The presence of nanotubes does
not aect the osteocalcin release.
The amount of free radicals and the degree of cells stim-
ulation has been measured by the chemiluminescence
method. The aim of this test was to nd out whether the
macrophages might undergo activation and release free
radicals in contact only with carbon nanotubes, or with
carbon particles of size similar to nanotubes. As shown
in Fig. 9, neither the nanotubes, nor the carbon particles
of similar dimension which were obtained by carbonization
of phenolformaldehyde resin, can activate the macro-
phages to release free radicals, which under specic circum-
stances could be toxic for both the surrounding cells and
tissues.
4. Conclusion
The cellular tests performed in this study conrm a good
biocompatibility of nanotubes, which is similar to that of
polysulfone currently used in medicine. The high level of
viability of the examined cells in contact with the nano-
tubes, the unchanged level of osteocalcin released from
osteoblasts, the lack of pro-inammatory IL-6 cytokine
as well as free radicals induction, point out a good cellular
biocompatibility of nanotubes. The slight increase of colla-
gen formation induced on nanotubes by both broblasts
and osteoblasts may be signicant for future medical appli-
cations of nanotubes, in particular as substrates for the tis-
sue regeneration.
The detrimental eects of a possible release of nanopar-
ticles into the human body should be investigated in the
future.
References
[1] Evans AC. Diamond-like carbon applied to bioengineering materials.
Med Tech 1991;5:269.
[2] Lewandowska M, Komander J, Chopek J. Interaction between
carbon composites and bone after interabone implantation. J Biomed
Mater Res 1999;3:28996.
[3] Mitura S, Marciniak J, Niedzielski P, Paszenda Z. Diamond-coated
implants for traumatology. Eng Biomat 1999;78:6572.
[4] Stary V, Bacakowa L, Glogar P, Hornik J, Jirka I, Svorcik V.
Measurement of surface properties of pyrolytic graphite for biomed-
ical applications. Eng Biomat 2001;1719:101.
[5] Bolz A, Schaldach M. Articial heart valves: improved blood
compatibility by PECVD a-SiC:H coating. Artif Organs 1990;14:
2609.
[6] Czajkowska B, Blazewicz M. Phagocytosis of chemically modied
carbon materials. Biomaterials 1997;18:6974.
[7] Ueda M, Sumi Y, Mizuno H, Honda M, Oda T, Wada K, et al.
Tissue engineering: applications for maxillofacial surgery. Mater Sci
Eng C 2000;13:714.
[8] Mendes DG, Roman M, Soundry MP. Composite ligament made of
carbon bre braids. Biomaterials and clinical applications. Amster-
dam: Elsevier Publishing BV; 1987, p. 2416.
[9] Aoyagi S, Oryoji A, Nishi Y, Tanaka K, Kosuga K, Oishi K. Long-
term results of valve replacement with the St. Jude Medical valve.
J Thorac Cardiovasc Surg 1994;108:10219.
[10] Chopek J, Ba_zewicz M, Pamua E, Kus WM, Staszkow E. Carbon
bres-based composites for the treatment of hard tissue injuries. In:
Proc Carbon 2001, Lexington, Kentucky, USA, 1419 July 2001.
[11] Tanaka K, Yamabe T, Fukui K. The science and technology of
carbon nanotubes. Amsterdam: Elsevier; 1999.
[12] Salvetat JP, Kulik A, Bonard JM, Andrew G, Briggs D, Stockli T,
et al. Elastic modulus of ordered and disordered multiwalled carbon
nanotubes. Adv Mater 1999;2:1615.
[13] Supronowicz PR, Ullman KR, Ajayan PM, Arulanandam BP,
Metzger DW, Bizios R. Cellular/molecular responses of electrically
stimulated osteoblasts cultured on novel polymer/carbon nanophase
substrates. In: Proc. Carbon 2001, Lexington, Kentucky, USA, 1419
July 2001.
[14] Iijima S. Carbon nanotubes. Mater Res Soc Bull 1994:439.
[15] Dresselhaus MS, Dresselhaus G, Eklund PC. Science of fullerenes
and carbon nanotubes. San Diego, USA: Academic Press; 1996.
[16] Tsang SC, Chen YK, Harris PJF, Green MLH. A simple chemical
method of opening and lling carbon nanotubes. Nature 1994;372:
15962.
[17] Ong KG, Kichambare PD, Grimes CA. A carbon nanotubes-based
sensor for CO2 monitoring. In: Proc Carbon 2001, Lexington,
Kentucky, USA, 1419 July 2001.
[18] Harutyunyan AR, Pradhan BK, Sumanasekera GU, Korobko EY,
Kuznetsov AA. Carbon nanotubes for medical applications. Eur
Cells Mat 2002;3:847.
[19] Vert M, Li SM, Spenlehauer G, Guerin P. Bioresorbability and
biocompatibility of aliphatic polyesters. J Mater Sci: Mater Medicine
1992;3:43246.
[20] van Loon JJ, Bierkens J, Maes J, Schoeters GER. Polysulphone
inhibits nal dierentiation steps of osteogenesis in vitro. J Biomed
Mater Res 1995;29:115563.
[21] Chopek J, Kmita G. Non-metallic composite materials for bone
surgery. Eng Trans 2003;2:30723.
 J. Chopek et al. / Carbon 44 (2006) 11061111
[22] Wood A. Using carbon nanotubes to reinforce ceramics. Chemical
Week 2003; 1/8.
[23] Beguin F, Delpeux-Ouldriane S, Szostak K. A process for the mass
production of multiwalled carbon nanotubes. Japanese patent no.
5941/02 (15 January 2002), Canadian patent no. 2374848 (6 March
2002), USA patent no. 10/095121 (12 March 2002).
[24] Delpeux S, Szostak K, Frackowiak E, Bonnamy S, Beguin F. High
yield of pure multiwalled carbon nanotubes from the catalytic
decomposition of acetylene on in situ formed cobalt nanoparticles.
J Nanosci Nanotech 2002;2:4814.
[25] Barltrop JA. 5-(3-Carboxymathoxyphenyl)-2-(4,5-dimenthylthiaz-
oly)-3-(4-sulfophenyl) tetrazolium, inner salt (MTS) and related
analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide
1111
(MTT) reducing to purple water-soluble formazans a cell-viability
indicators. Bioorg Med Chem Lett 1991;1:611.
[26] Bacakova L, Stary V, Glogar P. Adhesion and growth of cells in
culture on carboncarbon composites with dierent surface proper-
ties. Eng Biomat 1998;2:25.
[27] Elias KL, Price RL, Webster TJ. Enhanced functions of osteo-
blasts on nanometer diameter carbon bers. Biomaterials 2002;23:
327987.
[28] Price RL, Waid MC, Haberstroh KM, Webster TJ. Selective bone cell
adhesion on formulations containing carbon nanobers. Biomaterials
2003;24:187787.
[29] Rappolee DA, Werb Z. Secretory products of phagocytes. Curr Opin
Immunol 1988;1:4752.